Cancer Database Query Results

Scientific Papers found: Click to Expand⟱
7708- ,  lpi,    Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
- Trial, CRC, NA
PFS↑,
6864- ,    Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment
- Trial, AD, NA
*Risk↑, *cognitive↝,
6471- 1,8-Cin,    The Effect of 1,8-Cineole Inhalation on Preoperative Anxiety: A Randomized Clinical Trial
- Trial, Nor, NA
*ANXi↓,
5303- 5-HTP,    5-HTP shows early promise for cognitive support and in seniors: Singapore study
- Trial, AD, NA
*cognitive↑, *Dose↝, *5HT↑,
5288- 5-HTP,    The Impact of 5-Hydroxytryptophan Supplementation on Cognitive Function and Mood in Singapore Older Adults: A Randomized Controlled Trial
- Trial, AD, NA
*5HT↑, *cognitive↑, *BBB↑, *Mood↑,
5306- 5-HTP,    Tryptophan-enriched diet or 5-hydroxytryptophan supplementation given in a randomized controlled trial impacts social cognition on a neural and behavioral level
- Trial, AD, NA
*cognitive↑, *Dose↝,
5456- AF,    Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic Agent
- Trial, Nor, NA
*Dose?, *Half-Life↝, *Dose↑, *toxicity↝, *Bacteria↓, *Dose↑,
2462- AL,    Comparison of antiplatelet activity of garlic tablets with cardio-protective dose of aspirin in healthy volunteers: a randomized clinical trial
- Trial, Nor, NA
AntiAg∅,
3270- ALA,    Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis
- Trial, AD, NA
*cognitive↑, *other↝, *neuroP↑, *IronCh↑, *ROS↓, *GSH↑,
4282- ALA,    Effect of add-on alpha lipoic acid on psychopathology in patients with treatment-resistant schizophrenia: a pilot randomized double-blind placebo-controlled trial
- Trial, NA, NA
*antiOx↑, *Inflam↓, *lipid-P↓, *adiP↑, *cognitive∅, *BDNF↑,
5323- ALC,    Preventive Effect of Acetyl-L-carnitine on Oxaliplatin-induced Peripheral Neuropathy
- Trial, Var, NA
Pain↓, NP/CIPN↓,
5325- ALC,    L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial
- Trial, PC, NA
Weight↑, QoL↑, OS↑,
5315- ALC,    Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy
- Trial, BC, NA
other↑, NP/CIPN↑,
5316- ALC,    Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine
- Trial, BC, NA
NP/CIPN↑,
3975- ALC,    Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease
- Trial, AD, NA
*cognitive↑,
5361- almon,    Abstract CT190: A multicenter, open-label, single-arm, phase II study: The third generation EGFR tyrosine kinase inhibitor almonertinib for pretreated EGFR T790M-positive locally advanced or metastatic non-small cell lung cancer (APOLLO)
- Trial, NSCLC, NA
EGFR↓, OS↑, Dose↝,
5359- almon,    Aumolertinib as adjuvant therapy in resected EGFR-mutated non-small-cell lung cancer (ARTS): a double-blind, multicentre, randomised, controlled, phase 3 trial
- Trial, NSCLC, NA
eff↑, EGFR↓,
5357- almon,    AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations
- Trial, NSCLC, NA
EGFR↓, eff↝, OS↑,
7403- Amla,    Aqueous Extract of Emblica officinalis Linn (Indian gooseberry) in Combination with Iodine is More Efficacious than Iodine Alone in Mitigating Mucositis in Head and Neck Cancer Patients Undergoing Curative Radiotherapy: Retrospective Observations
- Trial, HNSCC, NA
Mucositis↓, Dose↝, Dose↝, *Bacteria↓, *AntiFungal↑, *AntiViral↑, *hepatoP↑, *RenoP↑, *neuroP↑, Dose↝,
7397- Amla,    Clinical evaluation of Emblica Officinalis Gatertn (Amla) in healthy human subjects: Health benefits and safety results from a randomized, double-blind, crossover placebo-controlled study
- Trial, Nor, NA
*Dose↝, *other↑, *LDL↓, *HDL↑, *toxicity↑, *ROS↓,
7408- Amla,    Fresh Phyllanthus emblica (Amla) Fruit Supplementation Enhances Milk Fatty Acid Profiles and the Antioxidant Capacities of Milk and Blood in Dairy Cows
- Trial, Nor, NA
*Dose↝, *TAC↑, *SOD↑, *Albumin↑, *ROS↓, *other↑,
7409- Amla,    Clinical evaluation of Emblica Officinalis Gatertn (Amla) in healthy human subjects: Health benefits and safety results from a randomized, double-blind, crossover placebo-controlled study
- Trial, Nor, NA
*HDL↑, *LDL↓, *ROS↓, *AntiAg↑, *TBARS↓, *Dose↝,
5382- ART/DHA,    A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies
- Trial, Var, NA
AntiCan↑, Dose↝, Dose↝,
5403- ASA,    Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer
- Trial, CRC, NA
Risk↓, other↝,
5416- ASA,    Cancer Incidence and Mortality With Aspirin in Older Adults
- Trial, Var, NA
Risk∅, OS∅,
5413- ASA,    Drug Resistance and Pseudoresistance: An Unintended Consequence of Enteric Coating Aspirin
- Trial, Nor, NA
*cardioP↑, *other↝, *COX1↓, *TXA2↓,
5399- ASA,    Effect of Aspirin on Cancer Incidence and Mortality in Older Adults
- Trial, Nor, NA
Risk↝, Risk↑, Risk∅, Risk↑, other↝,
5406- ASA,    Adjuvant aspirin therapy and colorectal cancer survival
- Trial, CRC, NA
Dose↝, OS∅,
5407- ASA,    Low-dose aspirin reduces the risk of colorectal cancer recurrence in patients with resected PI3K-altered localised disease, according to the ALASCCA trial.
- Trial, CRC, NA
Dose↝, Risk↓,
5394- Ash,    Safety and pharmacokinetics of Withaferin-A in advanced stage high grade osteosarcoma: A phase I trial
- Trial, OS, NA
toxicity↝, hepatoP↓, BioAv↓, Apoptosis↑, ROS↑, TumCCA↑,
5426- ASTX,  Cisplatin,    Astaxanthin Prevents a Decrease of Hemopoietic Activity in Head and Neck Cancer Patients Receiving Cisplatin Chemotherapy (Randomized Controlled Trial)
- Trial, HNSCC, NA
ROS↓, SOD↑, MDA↓, eff↑,
5372- ATO,    Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
- Trial, APL, NA
Remission↑, OS↑, toxicity↓,
5375- ATO,    Improved Outcome with ATRA-Arsenic Trioxide Compared to ATRA-Chemotherapy in Non-High Risk Acute Promyelocytic Leukemia – Updated Results of the Italian-German APL0406 Trial on the Extended Final Series
- Trial, APL, NA
eff↑, OS↑,
5374- ATO,    A pharmacokinetic and safety study of oral arsenic trioxide in patients with acute promyelocytic leukemia
- Trial, APL, NA
toxicity↓, OS↑,
5453- ATV,    Epidemiologic Analysis Along the Mevalonate Pathway Reveals Improved Cancer Survival in Patients Who Receive Statins Alone and in Combination With Bisphosphonates
- Trial, Var, NA
OS↑, eff↑, other↝,
5368- AV,    Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms
- Trial, HNSCC, NA
radioP↝,
5367- AV,  Rad,    Aloe vera for prevention of radiation-induced dermatitis: a self-controlled clinical trial
- Trial, Var, NA
radioP↑, Dose↝, eff↑,
5370- AV,    The Effect of Aloe Vera Solution on Chemotherapy-Induced Stomatitis in Clients with Lymphoma and Leukemia: A Randomized Controlled Clinical Trial
- Trial, AML, NA
Dose↝, stomatitis↓, Pain↓,
5576- B-Gluc,  Chemo,    Lentinan prolonged survival in patients with gastric cancer receiving S-1-based chemotherapy
- Trial, GC, NA
OS↑, eff↑,
5578- B-Gluc,    A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group
- Trial, GC, NA
OS↑, QoL↑,
5500- Ba,    Safety, tolerability, and pharmacokinetics of oral baicalein tablets in healthy Chinese subjects: A single‐center, randomized, double‐blind, placebo‐controlled multiple‐ascending‐dose study
- Trial, Nor, NA
*toxicity↓, *BioAv↑, *Half-Life↝, *Dose↝,
2695- BBR,    The effects of Berberis vulgaris consumption on plasma levels of IGF-1, IGFBPs, PPAR-γ and the expression of angiogenic genes in women with benign breast disease: a randomized controlled clinical trial
- Trial, BC, NA
IGF-1↓, PPARγ↓, VEGF↓, Hif1a↓, angioG↓,
5514- bemA,    Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients
- Trial, Nor, NA
*ACLY↓, *LDL↓, *MusCon↓, Dose↝, cardioP↑,
3987- betaCar,  Lyco,    Carotenoid bioavailability is higher from salads ingested with full-fat than with fat-reduced salad dressings as measured with electrochemical detection
- Trial, AD, NA
*eff↑,
3988- betaCar,  Lut,  Zeax,    Effects of egg consumption on carotenoid absorption from co-consumed, raw vegetables
- Trial, AD, NA
*eff↑, *eff↑, *eff↑,
5717- BF,  Chemo,  GEM,    Prospective randomised evaluation of traditional Chinese medicine combined with chemotherapy: a randomised phase II study of wild toad extract plus gemcitabine in patients with advanced pancreatic adenocarcinomas
- Trial, Var, NA
OS∅,
5716- BF,    Pilot Study of Huachansu in Patients with Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, or Pancreatic Cancer
- Trial, NSCLC, NA - Trial, PC, NA - Trial, HCC, NA
Dose↝, toxicity↓, other↓, QoL↑, OS?,
5661- BNL,    A clinical and mechanistic study of topical borneol‐induced analgesia
- Trial, Nor, NA
*Pain↓,
1248- Bos,    The anti-proliferative effects of a frankincense extract in a window of opportunity phase ia clinical trial for patients with breast cancer
- Trial, BC, NA
TumCP↓,
5736- Buty,    Clinical and pharmacologic study of tributyrin: an oral butyrate prodrug
- Trial, Var, NA
Dose↝, BioAv↝, toxicity↓, OS↝,

Showing Research Papers: 1 to 50 of 435
Page 1 of 9 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 435

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

2/16-OHE1↑, 1,   8-oxo-dG↓, 1,   ADCY4↑, 1,   AEs∅, 1,   APG↓, 2,   CIT↓, 1,   CR↑, 2,   DCR↑, 3,   DCR↝, 1,   ENL↑, 1,   IGF-2R↑, 1,   Ingr↑, 1,   JAG1↑, 1,   LC↑, 1,   mal↓, 1,   miR-106b↓, 1,   Mucositis↓, 4,   Nausea↓, 4,   Nausea∅, 2,   NEU1↑, 1,   NLR↓, 1,   ORR↑, 3,   ORR∅, 1,   PC↑, 3,   PFS↑, 4,   PFS∅, 1,   PGI2↓, 1,   RBC↑, 3,   RFS↑, 1,   TTP↑, 1,   UFR↑, 1,   Vomit↓, 4,   Vomit∅, 2,   WBC↑, 2,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 2,   Bil∅, 1,   Copper↓, 2,   CoQ10↑, 1,   GSH↓, 1,   MDA↓, 1,   ROS↓, 3,   ROS↑, 5,   ROS↝, 2,   SOD↑, 1,   TrxR↓, 1,   VitC↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

selm↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

BCR-ABL↓, 1,   Insulin↓, 2,   MPT↑, 1,   PGC-1α↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ALAT↓, 2,   BUN↓, 1,   CYP3A4⇅, 1,   FAO↑, 1,   lactateProd↓, 1,   PDK1 / PDPK1↓, 2,   PPARγ↓, 1,  

Cell Death(tgid=5) ⓘ

p‑Akt↓, 1,   Apoptosis↑, 6,   Bcl-2↓, 3,   Bcl-xL↓, 2,   Cyt‑c↝, 1,   IAP1↓, 1,   Mcl-1↓, 3,   Myc↓, 1,   NOXA↑, 1,   PUMA↑, 1,   survivin↓, 1,   TRPV1↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

miR-30a-5p↑, 1,   other?, 1,   other↓, 4,   other↑, 6,   other↝, 18,   other∅, 3,   SD↑, 4,  

Autophagy & Lysosomes(tgid=9) ⓘ

TumAuto↓, 1,   TumAuto↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

NKX3.1↓, 1,   P53↑, 1,   RAD51↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

cycD1/CCND1↓, 2,   P21↑, 3,   TumCCA↑, 5,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ALDH↓, 1,   CSCs↓, 2,   HDAC↓, 4,   HH↓, 3,   HH∅, 1,   IGF-1↓, 7,   IGF-1↑, 1,   IGFBP1↑, 2,   IGFBP3↓, 1,   IGFBP3↑, 1,   IGFR↓, 1,   NOTCH3↑, 1,   PI3K↓, 1,   PTEN↑, 2,   Smo↓, 1,   TumCG↓, 7,   Wnt↓, 1,  

Migration(tgid=13) ⓘ

5LO↓, 1,   AntiAg↑, 1,   AntiAg↝, 1,   AntiAg∅, 1,   Ca+2↓, 1,   Ca+2↑, 1,   GLI3↓, 1,   Ki-67↓, 6,   miR-19b↓, 1,   miR-29b↑, 1,   MMP2↓, 1,   MMP9↓, 2,   MMP9:TIMP1↑, 1,   Slug↓, 1,   p‑SMAD2↓, 1,   p‑SMAD3↓, 1,   TGF-β↓, 1,   TIMP1↓, 1,   TumCA↓, 1,   TumCI↓, 3,   TumCMig↓, 2,   TumCP↓, 9,   TumMeta↓, 1,   TumMeta↑, 1,   Twist↓, 1,   Vim↓, 1,   ZO-1↓, 1,   β-catenin/ZEB1↓, 2,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 8,   angioG∅, 1,   EGFR↓, 3,   Endoglin↓, 1,   Hif1a↓, 1,   VEGF↓, 3,   VEGFR2/KDR/Flk1↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   IBI↑, 1,   P-gp/ABCB1↓, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD14↓, 1,   CD25+↓, 1,   CD4+↓, 1,   CD4+↑, 1,   cellSen?, 1,   COX2/PTGS2↓, 4,   COX2/PTGS2∅, 1,   CRP↓, 2,   FoxP3+↓, 1,   GM-CSF↓, 1,   IFN-γ↑, 1,   IL10↓, 1,   IL12↓, 1,   IL18↑, 1,   IL1β↓, 1,   IL1β∅, 1,   IL22↓, 1,   IL6↓, 4,   Imm↑, 11,   INF-γ↝, 1,   Inflam↓, 7,   LIF↑, 1,   MCP1/CCL2↓, 1,   Neut↓, 1,   Neut↑, 2,   NF-kB↓, 2,   NK cell↑, 4,   PDT+↓, 1,   PGE2↓, 2,   PSA↓, 10,   T-Cell↑, 1,   TNF-α↓, 1,   TNF-α∅, 1,   VitD↑, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 2,   AR↝, 1,   DHT↓, 1,   EstroRS/ERS↑, 1,   testos↓, 1,   testos∅, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 2,   BioAv↑, 9,   BioAv↝, 8,   BioEnh↑, 1,   ChemoSen↑, 6,   ChemoSen∅, 1,   CYP1A2↑, 1,   Dose?, 2,   Dose↓, 3,   Dose↑, 7,   Dose↝, 117,   Dose∅, 4,   eff↓, 2,   eff↑, 42,   eff↝, 6,   eff∅, 7,   Half-Life↑, 1,   Half-Life↝, 6,   RadioS↑, 4,   selectivity↑, 5,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 2,   ALC↓, 1,   AR↓, 2,   AR↝, 1,   AST↓, 2,   BG↓, 1,   Bil∅, 1,   CA125↓, 1,   CA125∅, 1,   CA19-9↓, 1,   CEC↝, 1,   creat↓, 1,   CRP↓, 2,   CTC↓, 1,   EGFR↓, 3,   EstroRS/ERS↑, 1,   GutMicro↑, 1,   HemoG↑, 1,   IL6↓, 4,   Ki-67↓, 6,   Myc↓, 1,   PSA↓, 10,   VitD↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↓, 1,   AntiCan↑, 6,   antiNeop↑, 1,   AntiTum↑, 3,   AntiTum∅, 1,   cachexia↓, 1,   cardioP↑, 3,   CardioT↑, 1,   CardioT↝, 1,   chemoP↑, 6,   chemoP∅, 1,   chemoPv↑, 5,   ChemoSideEff↓, 2,   fatigue↓, 3,   hepatoP↓, 1,   hepatoP↑, 2,   memory↑, 1,   NP/CIPN↓, 2,   NP/CIPN↑, 3,   Obesity↓, 1,   OS?, 1,   OS↑, 48,   OS↝, 1,   OS∅, 9,   Pain↓, 8,   QoL↑, 16,   QoL∅, 3,   radioP?, 1,   radioP↑, 5,   radioP↝, 1,   Remission↑, 3,   Risk↓, 13,   Risk↑, 2,   Risk↝, 2,   Risk∅, 4,   stomatitis↓, 1,   Strength↑, 1,   Strength∅, 1,   toxicity↓, 25,   toxicity↑, 1,   toxicity↝, 19,   toxicity∅, 1,   TumVol↓, 4,   TumW↓, 1,   Weight↑, 5,   Weight∅, 1,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

CD8+↑, 3,   Diar↓, 1,   Diar⇅, 1,   Inf↓, 4,   Sepsis↓, 1,  
Total Targets: 277

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0) ⓘ

12-HETE↓, 1,   2/16-OHE1↑, 1,   5-HETE↓, 1,   AcOH↑, 2,   AntiBio↑, 2,   BDI↓, 1,   Buty↑, 3,   CCr / CrCl↓, 1,   CCr / CrCl∅, 1,   Eic↓, 1,   END↑, 1,   ENL↑, 1,   Eos↓, 1,   FEV1↑, 2,   FFA/NEFA↝, 1,   HRV↑, 1,   IgE↓, 1,   Ingr↝, 1,   IPSS↓, 1,   Learn↑, 1,   NLR↓, 1,   NMSS↓, 1,   PA↑, 2,   PCO↓, 1,   PEF↑, 1,   rHR↓, 1,   RT↓, 2,   SCFAs↑, 3,   SCFAs∅, 1,   Stress↓, 4,   Tinn↓, 1,   TMAO∅, 1,   UFR↑, 1,   UPDRS↓, 1,   UPDRSIII∅, 1,   UR↓, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 11,   Bil↓, 2,   Catalase↑, 1,   GPx↑, 1,   GSH↑, 5,   HDL↓, 2,   HDL↑, 4,   HO-1↑, 1,   Iron↓, 1,   lipid-P↓, 2,   MDA↓, 4,   MDA↑, 1,   MPOD↑, 2,   NRF2↑, 2,   ROS↓, 16,   SAM-e↓, 1,   SOD↑, 3,   TAC↑, 3,   TBARS↓, 1,   uricA↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

mitResp↑, 1,   mtDam↓, 1,   PGC-1α↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ACLY↓, 1,   adiP↑, 1,   ALAT↓, 3,   ALAT∅, 1,   AMPK↑, 1,   CRM↑, 1,   DHA↑, 2,   glucose∅, 1,   KeyT↝, 1,   lactateProd↓, 1,   LDH↓, 3,   LDL↓, 9,   NH3↓, 1,   SIRT1↑, 1,  

Cell Death(tgid=5) ⓘ

BAX↓, 1,   Casp3↓, 1,   CK2↓, 1,   p38↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

Ach↑, 2,   AntiThr↑, 3,   other?, 3,   other↓, 3,   other↑, 16,   other↝, 14,   other∅, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 1,   DNArepair↑, 1,   DNMT3A↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Choline↑, 1,   Diff↝, 1,   EP2↑, 1,   HDAC3↓, 1,   IGF-1↓, 1,   IGF-1↑, 1,   IGFBP3↓, 1,   NOTCH↓, 1,   Wnt↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 4,   AntiAg∅, 1,   MMP9↓, 1,   TGF-β↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

NO↓, 1,   TXA2↓, 1,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   IBI↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD14↑, 1,   COX1↓, 1,   CRP↓, 4,   IFN-γ↓, 1,   IFN-γ↑, 3,   IL1↓, 1,   IL10↓, 1,   IL10↑, 1,   IL10∅, 1,   IL12↓, 1,   IL17∅, 1,   IL1β↓, 5,   IL4↑, 1,   IL4∅, 1,   IL6↓, 9,   IL8↓, 1,   Imm↑, 5,   Inflam↓, 23,   MCP1/CCL2↓, 1,   MCP1/CCL2↝, 1,   NF-kB↓, 1,   NK cell↑, 3,   PGE2↓, 2,   PSA↓, 1,   TNF-α↓, 8,   TNF-α↑, 3,   VitD↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 3,   AChE↓, 4,   BDNF↑, 7,   BDNF∅, 1,   BrainVol↑, 1,   BrainVol↝, 1,   BrainVol∅, 3,   GABA↑, 1,   tau↓, 3,   p‑tau↓, 1,  

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 10,   Aβ∅, 1,   BACE/β-secretase↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

cortisol↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 4,   BioAv↑, 18,   BioAv↝, 12,   Dose?, 6,   Dose↓, 1,   Dose↑, 7,   Dose↝, 111,   eff↓, 1,   eff↑, 21,   eff↝, 7,   eff∅, 1,   Half-Life↓, 2,   Half-Life↑, 2,   Half-Life↝, 19,   P450↓, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 3,   ALAT∅, 1,   Albumin↑, 2,   ALP↓, 1,   AST↓, 1,   AST∅, 1,   Bil↓, 2,   BloodF↑, 3,   BMD↑, 1,   BP↓, 12,   BP∅, 1,   CRP↓, 4,   GutMicro↑, 6,   GutMicro∅, 1,   Hcy/homoC↓, 13,   Hcy/homoC↝, 1,   HemoG↑, 1,   hs-CRP↓, 1,   IL6↓, 9,   LDH↓, 3,   PSA↓, 1,   TG/TAG↓, 1,   VitD↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 1,   AntiCan↑, 2,   AntiDiabetic↑, 2,   AntiTum↑, 3,   ANXi↓, 2,   cardioP↑, 5,   chemoP↑, 3,   cognitive?, 1,   cognitive↓, 1,   cognitive↑, 68,   cognitive↝, 2,   cognitive∅, 12,   fatigue↓, 2,   GFR↓, 1,   GFR∅, 1,   hepatoP↑, 5,   memory↑, 23,   memory∅, 1,   Mood↑, 7,   motorD↑, 9,   MusCon↓, 1,   neuroP↑, 12,   Obesity↓, 2,   Pain↓, 8,   QoL?, 1,   QoL↑, 10,   RenoP↑, 3,   Risk↓, 5,   Risk↑, 2,   Risk↝, 1,   Sleep↑, 6,   Strength↑, 4,   toxicity?, 1,   toxicity↓, 31,   toxicity↑, 1,   toxicity↝, 3,   toxicity∅, 7,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiFungal↑, 2,   AntiViral↑, 4,   Bacteria↓, 2,  
Total Targets: 227

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:%  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page